000			03533nam a22004215i 4500
999			_c381981 _d381981 _x1
001			381981
003			ES-MaUEC
005			20230102121944.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			220924s2022 sz | s |||| 0|eng d
020			_a9783030943837
024	7		_a10.1007/978-3-030-94383-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC523 _b2022 EB
245	0	0	_aPharmacological Treatment of Alzheimer's Disease : _bScientific and Clinical Aspects _cedited by Gustavo Alves Andrade dos Santos
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XIV, 231 páginas) _b11 ilustraciones, 5 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_a1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer's Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
520			_aAlzheimer's disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer's disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer's disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer's disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer's disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
988			_aSpringer_Medicine_2022
650		7	_2embne _9144620 _aAlzheimer, Enfermedad de
700	1		_aSantos, Gustavo Alves Andrade dos _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
773	0		_tSpringer Nature eBook
776	0	8	_iPrinted edition: _z9783030943820
776	0	8	_iPrinted edition: _z9783030943844
776	0	8	_iPrinted edition: _z9783030943851
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-94383-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b09/2022 _dz _eIG _zSI